Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

New Greek therapeutic protocols fight "high cost prescribing"

This article was originally published in Scrip

Executive Summary

Greece is planning to introduce later this month its first tranche of therapeutic/prescribing protocols for common and serious diseases to fight against "provoked, incorrect and high cost prescribing", Professor Yannis Tountas, the president of the Greek drug regulator, the National Organisation for Medicines (EOF), told Scrip. The first of the protocols will be available by the end of this month and will cover rheumatoid arthritis and venous thrombosis.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

SC010897

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel